A7409
Seroalbúmina bovina solution
35% in 0.85% sodium chloride, aseptically filled
Sinónimos:
Albúmina solution from bovine serum, Disolución BSA
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Productos recomendados
origen biológico
bovine
Nivel de calidad
descripción
contains no preservative
esterilidad
aseptically filled
formulario
solution
purificado por
heat shock fractionation
origen
USA origin
concentración
33.0-37.4% protein (biuret)
35% in 0.85% sodium chloride
técnicas
microbiological culture: suitable
Nº de acceso UniProt
temp. de almacenamiento
2-8°C
Información sobre el gen
bovine ... ALB(280717)
¿Está buscando productos similares? Visita Guía de comparación de productos
Descripción general
Albumin belongs to the four-member albumin superfamily. It is a major protein in the circulating blood. Albumin has a helical structure with three domains that form a heart-like shape.
Aplicación
Bovine Serum Albumin solution has been used:
- to block protein-coated well plates in enzyme-linked immunosorbent assay (ELISA) for immunoreactivity and cross-reactivity studies in the production of monoclonal antibodies (mAbs)
- to prepare primary antibody solution for peroxidases staining
- as a supplement for in vitro cultivation of Borrelia strains
Acciones bioquímicas o fisiológicas
Bovine serum albumin (BSA) serves as a protein supplement for cell culture media. BSA acts as a transport carrier for drugs, and it is commonly used to study the protein-drug interactions. Furthermore, it is known for its ability to interact with several aromatic and hydrophobic molecules of the bloodstream.
Código de clase de almacenamiento
10 - Combustible liquids
Clase de riesgo para el agua (WGK)
WGK 3
Punto de inflamabilidad (°F)
Not applicable
Punto de inflamabilidad (°C)
Not applicable
Equipo de protección personal
Eyeshields, Gloves
Choose from one of the most recent versions:
Certificados de análisis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Los clientes también vieron
Sabrina Hepner et al.
Ticks and tick-borne diseases, 10(5), 1157-1161 (2019-06-27)
Borrelia turcica is a reptile-associated Borrelia species that is vectored by the hard tick Hyalomma aegyptium. Tortoises of the genus Testudo represent the principal host of adult H. aegyptium, while immature stages are less host-specific and can be found on
Chengjin Ye et al.
Microbiology spectrum, 10(6), e0273222-e0273222 (2022-11-08)
Reporter-expressing recombinant virus represents an excellent option and a powerful tool to investigate, among others, viral infection, pathogenicity, and transmission, as well as to identify therapeutic compounds that inhibit viral infection and prophylactic vaccines. To combat the ongoing coronavirus disease
Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
Fatai S Oladunni et al.
Journal of virological methods, 290, 114084-114084 (2021-01-30)
The use of monoclonal neutralizing antibodies (mNAbs) is being actively pursued as a viable intervention for the treatment of Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) infection and associated coronavirus disease 2019 (COVID-19). While highly potent mNAbs have great therapeutic potential
Laura Burbaum et al.
Nature communications, 12(1), 4086-4086 (2021-07-04)
Sarcomeres, the basic contractile units of striated muscle, produce the forces driving muscular contraction through cross-bridge interactions between actin-containing thin filaments and myosin II-based thick filaments. Until now, direct visualization of the molecular architecture underlying sarcomere contractility has remained elusive.
Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
Fatai S Oladunni et al.
Journal of virological methods, 290, 114084-114084 (2021-01-30)
The use of monoclonal neutralizing antibodies (mNAbs) is being actively pursued as a viable intervention for the treatment of Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) infection and associated coronavirus disease 2019 (COVID-19). While highly potent mNAbs have great therapeutic potential
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico